Na, Y. M.

Publications

P223

Pharmaceuticals. 2020, 13, 186.

Optimization, Antifungal Activity, Selectivity, and CYP51 Binding of New 2-Aryl-3-azolyl-1-indolyl-propan-2-ols.

Lebouvier, N. Pagniez, F. Na, Y. M. Shi, D. Pinson, P. Marchivie, M. Guillon, J. Hakki, T. Bernhardt, R. Yee, S. W. Simons, C. Lézé, M.-P. Hartmann, R. W. Mularoni, A. Le Baut, G. Krimm, I. Abagyan, R. Le Pape, P. Le Borgne, M. Synthesis,

doi:10.3390/ph13080186

P208

J. Enzym. Inhib. Med. Chem. 2020, 35, 398-403.

Biological exploration of a novel 1,2,4-triazole-indole hybrid molecule as antifungal agent.

Pagniez, F. Lebouvier, N. Na, Y. M. Ourliac-Garnier, I. Picot, C. Le Borgne, M. Le Pape, P.

doi: 10.1080/14756366.2019.1705292

Thèse

T02.

Azoles inhibiteurs de la 14α-déméthylase à activité antifongique et / ou antileishmanienne.

Na, Y. M.

Nantes, 22 septembre 2000.